Grand Pharmaceutical (China) Co., Ltd. is a comprehensive pharmaceutical enterprise integrating R&D, production and sales of various preparations, medical devices and chemical raw materials and other products
Grand Pharma (China) Co. Ltd. is a modern pharmaceutical group with a glorious history of more than 70 years, formerly known as a pharmaceutical institute in the Taihang Mountain Revolutionary Base Area of the Eighth Route Army, which has made great contributions to the War of Resistance against Japanese Aggression and the War of Liberation. In 2002, he joined China Grand Group, and in 2008, he became the core enterprise of its parent company, Grand Pharmaceutical and Health Holdings Limited (stock code: HK0512), a Hong Kong-listed company.
Grand Pharma currently has more than 10 member companies, and is a comprehensive pharmaceutical enterprise integrating various preparations, medical devices and chemical APIs. The company's core products cover three major business areas represented by ENT, cardiovascular emergency preparations/devices, biotechnology and characteristic APIs, forming cardiovascular drugs with Xinweining as the core; ophthalmic drugs with rejuvenated and white arrest as the core; ENT drugs with Cheno, Norton as the core; Medical devices with ocular surface test strips and ophthalmic surgery consumables as the core; and high-end amino acids and their derivatives prepared by a variety of bioengineering technologies. In recent years, Grand Pharma has maintained an annual growth rate of more than 30% in sales revenue and profit by comprehensively promoting strategic transformation, transforming development mode, accelerating independent innovation, and continuously expanding product markets.
Among the more than 5,000 team members owned by the company, there are more than 1,300 professional promotion teams and an independent R&D and technology center based on more than 200 R&D technical talents (60% of employees with master's degree or above), and a number of drug R&D experts with international professional level from the United States, New Zealand, Australia and India and other countries, and a number of domestic and foreign experts are hired as long-term consultants. The team of knowledgeable and practical professionals supports Grand Pharma's continuous innovation, breakthrough and development in the pharmaceutical field, and enables Grand Pharma to gain the first opportunity and gain in international operation and global competition.
Grand Pharma has always adhered to the enterprise spirit of "daring to be the first and sharing success", with the business philosophy of "providing good products and cultivating a high realm", focusing on transformation and upgrading, continuously improving the core business advantages of the enterprise and creating new needs; Through the modern management platform and professional technology platform, the company is promoted to move towards the goal of modernization and internationalization, and strives to become a pharmaceutical enterprise respected by Chinese doctors and patients.
